RAPH Raphael Pharmaceutical Inc.
Fundamentals / CIK 0001415397 / USDRaphael Pharmaceutical Inc. reported $7.0K in total assets and a net loss of $980K through December 31, 2025 from SEC EDGAR filings.
Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open RAPH in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.
-
Revenue FY 2025-- Dec 31, 2025
-
Operating Income FY 2025-$927K Operating profit
-
Net Income FY 2025-$980K GAAP bottom line
-
Diluted EPS FY 2025-$0.05 Split-adjusted
-
Free Cash Flow FY 2025-- Operating CF less CapEx
-
Cash & ST Investments Jun 30, 2026-- Total debt: --
Annual revenue and net income
6 fiscal years (2020 to 2025), reported in USD.
Financial statements and ratios
Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.
Income Statement (Annual) · Reported in USD · Newest filing period first.
| Income Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Research & Development | $631K | $776K | $569K | $1.18M | $776K | $461K |
| Operating Income | -$1.25M | -$1.51M | -$1.33M | -$3.32M | -$1.63M | -$706K |
| Net Income | -$1.28M | -$1.52M | -$1.34M | -$3.36M | -$1.62M | -$718K |
| Basic EPS | $0.07 | $0.08 | $0.08 | $0.23 | $0.14 | $0.07 |
| Diluted EPS | $0.07 | $0.08 | $0.08 | $0.23 | $0.14 | $0.07 |
| Basic Shares Outstanding | 19.6M | 18.7M | 16.7M | 14.3M | 11.2M | 9.5M |
| Diluted Shares Outstanding | 19.6M | 18.7M | 16.7M | 14.3M | 11.2M | 9.5M |
Income Statement (Quarterly) · Reported in USD · Newest filing period first.
| Income Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Research & Development | $40K | $37K | $345K | $73K | $141K | $72K | $211K | $162K |
| Operating Income | -$199K | -$223K | -$254K | -$251K | -$315K | -$425K | -$394K | -$319K |
| Interest Expense | -- | $3.0K | -- | -- | -- | -- | -- | -- |
| Net Income | -$223K | -$229K | -$273K | -$255K | -$322K | -$429K | -$395K | -$326K |
| Basic EPS | $0.01 | $0.01 | -- | $0.01 | $0.02 | $0.02 | -- | $0.01 |
| Diluted EPS | $0.01 | $0.01 | -- | $0.01 | $0.02 | $0.02 | -- | $0.01 |
| Basic Shares Outstanding | 20.2M | 20.2M | -- | 19.6M | 19.6M | 19.6M | -- | 18.7M |
| Diluted Shares Outstanding | 20.2M | 20.2M | -- | 19.6M | 19.6M | 19.6M | -- | 18.7M |
Balance Sheet (Annual) · Reported in USD · Newest filing period first.
| Balance Sheet | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | $19K | $230K | $288K | $153K | $95K |
| Cash & Short-Term Investments | -- | $19K | $230K | $288K | $153K | $95K |
| Accounts Receivable, Net | $2.0K | $2.0K | -- | -- | -- | -- |
| Other Current Assets | $6.0K | $6.0K | $7.0K | $43K | $269K | $228K |
| Total Current Assets | $51K | $25K | $237K | $331K | $422K | $323K |
| Property, Plant & Equipment, Net | $2.0K | $2.0K | $2.0K | -- | -- | -- |
| Intangible Assets | -- | -- | $2.0K | $2.0K | -- | -- |
| Total Non-Current Assets | $2.0K | $2.0K | $2.0K | $2.0K | $0 | $0 |
| Total Assets | $53K | $27K | $239K | $333K | $422K | $323K |
| Accounts Payable | $163K | $125K | $69K | $72K | $107K | $9.0K |
| Short-Term Debt | -- | $41K | -- | -- | -- | $357K |
| Total Current Liabilities | $1.49M | $769K | $132K | $227K | $294K | $366K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.49M | $769K | $132K | $227K | $294K | $366K |
| Total Debt (incl. Leases) | -- | $41K | -- | -- | -- | $357K |
| Common Stock | $202K | $187K | $185K | $157K | $130K | $95K |
| Retained Earnings | -$10.17M | -$8.89M | -$7.37M | -$6.03M | -$2.67M | -$1.04M |
| Total Stockholders' Equity | -$1.43M | -$742K | $107K | $106K | $128K | -$43K |
| Total Equity | -$1.43M | -$742K | $107K | $106K | $128K | -$43K |
Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.
| Balance Sheet | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash & Cash Equivalents | -- | -- | -- | -- | $20K | $50K | $19K | $40K |
| Cash & Short-Term Investments | -- | -- | -- | -- | $20K | $50K | $19K | $40K |
| Accounts Receivable, Net | -- | -- | $2.0K | -- | -- | -- | $2.0K | -- |
| Other Current Assets | $5.0K | -- | $6.0K | $2.0K | $8.0K | $41K | $6.0K | $9.0K |
| Total Current Assets | $6.0K | $1.0K | $51K | $5.0K | $28K | $91K | $25K | $49K |
| Property, Plant & Equipment, Net | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Total Non-Current Assets | $1.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K | $2.0K |
| Total Assets | $7.0K | $3.0K | $53K | $7.0K | $30K | $93K | $27K | $51K |
| Accounts Payable | -- | -- | $163K | -- | -- | -- | $125K | -- |
| Short-Term Debt | -- | -- | -- | -- | -- | -- | $41K | -- |
| Total Current Liabilities | $1.89M | $1.67M | $1.49M | $1.27M | $1.08M | $827K | $769K | $667K |
| Total Non-Current Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.89M | $1.67M | $1.49M | $1.27M | $1.08M | $827K | $769K | $667K |
| Total Debt (incl. Leases) | -- | -- | -- | -- | -- | -- | $41K | -- |
| Common Stock | $202K | $202K | $202K | $196K | $196K | $9.0K | $187K | $187K |
| Retained Earnings | -$10.62M | -$10.40M | -$10.17M | -$9.89M | -$9.64M | -$9.32M | -$8.89M | -$8.43M |
| Total Stockholders' Equity | -$1.89M | -$1.66M | -$1.43M | -$1.26M | -$1.05M | -$734K | -$742K | -$616K |
| Total Equity | -$1.89M | -$1.66M | -$1.43M | -$1.26M | -$1.05M | -$734K | -$742K | -$616K |
Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.
| Cash Flow Statement | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Net Income | -$1.28M | -$1.52M | -$1.34M | -$3.36M | -$1.62M | -$718K |
| Stock-Based Compensation | $245K | $350K | $200K | $2.29M | -- | -- |
| Change in Payables | -- | -- | -$190K | $102K | $234K | -- |
| Operating Cash Flow | -$210K | -$532K | -$1.20M | -$759K | -$1.42M | -$779K |
| Capital Expenditure | -- | -- | -- | -$2.0K | -- | -- |
| Free Cash Flow | -- | -- | -- | -$761K | -- | -- |
| Investing Cash Flow | -- | -- | -- | -$2.0K | -- | -- |
| Common Stock Issued | $243K | $280K | $1.15M | -- | -- | -- |
| Financing Cash Flow | $236K | $321K | $1.15M | $896K | $1.48M | $824K |
| Net Change in Cash | $26K | -$211K | -$58K | $135K | $58K | $45K |
Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.
| Cash Flow Statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Net Income | -$223K | -$229K | -$273K | -$255K | -$322K | -$429K | -$395K | -$326K |
| Stock-Based Compensation | -- | -- | $1.0K | $39K | $8.0K | $197K | -- | -- |
| Change in Payables | -- | -- | -- | -- | -- | -- | -- | $249K |
| Operating Cash Flow | $0 | -$44K | $46K | -$17K | -$30K | -$209K | -$62K | -$80K |
| Common Stock Issued | -- | -- | $3.0K | $0 | $0 | $240K | $0 | $0 |
| Financing Cash Flow | -- | -- | -$4.0K | $0 | $0 | $240K | $41K | $0 |
| Net Change in Cash | $0 | -$44K | $42K | -$17K | -$30K | $31K | -$21K | -$80K |
Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.
| Ratios & Growth | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -- | -- | -1256.1% | -3167.9% | -1268.8% | -- |
| Return on Assets (ROA) | -2413.2% | -5625.9% | -562.3% | -1008.4% | -384.8% | -222.3% |
| Current Ratio | 0.03x | 0.03x | 1.80x | 1.46x | 1.44x | 0.88x |
| Quick Ratio | -- | 0.03x | 1.74x | 1.27x | 0.52x | 0.26x |
| EPS Growth (YoY) | -12.5% | 0.0% | -65.2% | +64.3% | +100.0% | -- |
Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.
| Ratios & Growth | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Return on Assets (ROA) | -14000.0% | -35966.7% | -2413.2% | -20014.3% | -4906.7% | -1503.2% | -5625.9% | -2082.4% |
| Current Ratio | 0.00x | 0.00x | 0.03x | 0.00x | 0.03x | 0.11x | 0.03x | 0.07x |
| Quick Ratio | -- | -- | -- | -- | 0.02x | 0.06x | 0.03x | 0.06x |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -632.4% | -- |
| Net Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -737.1% | -- |
| EPS Growth (YoY) | -50.0% | -50.0% | -- | 0.0% | +100.0% | -33.3% | -- | -75.0% |